DUBLIN--(BUSINESS WIRE)--The "Global Bariatric Surgery Market 2022-2028" report has been added to ResearchAndMarkets.com's offering.
The global bariatric surgery market is anticipated to grow at a substantial CAGR of 9.2% during the forecast period.
Growing prevalence of chronic diseases including diabetes and obesity, and increasing government funding are some major factors affecting the growth of the global bariatric surgery market. Obesity is a major health concern affecting a significantly large number of people around the world.
According to the National Institutes of Health, obesity and overweight together are the second leading cause of preventable death in the United States and an estimated 300,000 deaths per year are due to the obesity epidemic. Bariatric surgery is an effective treatment for severe obesity that outcomes in the improvement or remission of many obesity-related comorbid conditions and sustained weight loss.
As a result, Rising concerns about the disease have driven demand for bariatric surgeries. Furthermore, increasing government funding to improve healthcare facilities and hospitals is also expected to boost market growth during the forecast period. Adoption of these surgeries in the emerging markets, improving healthcare spending and growing disposable incomes are expected to create significant demand for bariatric surgery market. However, high costs associated with surgery and post-surgery complications may affect the growth of the market.
The Report Covers
- Comprehensive research methodology of the global bariatric surgery market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the global bariatric surgery market.
- Insights about market determinants that are stimulating the global bariatric surgery market.
- Detailed and extensive market segments with the regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
Key Topics Covered:
1. Report Summary
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.2. Cousin-Biotech
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. Johnson & Johnson Services, Inc.
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. Medtronic PLC
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. Olympus Corp.
3.5.1. Overview
3.5.2. Financial Analysis
3.5.3. SWOT Analysis
3.5.4. Recent Developments
3.6. ReShape Lifesciences, Inc.
3.6.1. Overview
3.6.2. Financial Analysis
3.6.3. SWOT Analysis
3.6.4. Recent Developments
3.7. Key Strategy Analysis
3.8. Impact of Covid-19 on Key Players
4. Market Segmentation
4.1. Global Bariatric Surgery Market by Procedures
4.1.1. Biliopancreatic Diversion with a Duodenal Switch (bpd-ds)
4.1.2. Adjustable Gastric Band Surgery
4.1.3. Sleeve Gastrectomy Surgery
4.1.4. Gastric Bypass Surgery
4.2. Global Bariatric Surgery Market by Devices
4.2.1. Gastric Bands
4.2.2. Gastric Balloons
4.2.3. Gastric Stapling Device
4.2.4. Others (Adjustable Gastric Bands and Bariatric Bed)
4.3. Global Bariatric Surgery Market by End-User
4.3.1. Hospitals and Clinics
4.3.2. Ambulatory Surgical Centers
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. Allergan PLC
6.2. Apollo Endosurgery Inc.
6.3. Asensus Surgical, Inc.
6.4. Aspire Bariatrics, Inc.
6.5. EndoGastric Solutions, Inc.
6.6. Gelesis, Inc.
6.7. GI Dynamics, Inc.
6.8. Mediflex Surgical Products
6.9. Sklar Surgical Instruments
6.10. Spatz FGIA Inc.
6.11. Stryker Corp.
6.12. USGI Medical, Inc.
6.13. W. L. Gore & Associates, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/yxzoxa
